Sponsor hub

Oregon Health and Science University clinical trial failures

Review 33 stopped clinical trials from Oregon Health and Science University, including disease areas, phases, and classified stop reasons.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 0 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials33
Likely biological signals0
Shown below33

Dominant stop reasons

OPERATIONAL
18
OTHER/UNKNOWN
15

Notable sponsors

Oregon Health and Science University
33

Related phases

Unknown
12
Phase II
7
Phase IV
7
Early Phase I
4
Phase I
3

Crawlable stopped-trial records

Open Explore

Showing up to 33 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT00688935: Young Blind Child Melatonin Treatment Study

Unknown Blindness trial by Oregon Health and Science University. Stop reason: OTHER/UNKNOWN.

Unique provision in the American Recovery and Reinvestment Act prevented approval of second year no-cost-extension in which completion of analyses were planned.

NCT00795236: Melatonin Studies of Totally Blind Children

Unknown Sleep Disorder trial by Oregon Health and Science University. Stop reason: OTHER/UNKNOWN.

Unique provision in the American Recovery and Reinvestment Act prevented approval of second year no-cost-extension in which completion of analyses were planned.

NCT00691444: Blind Child Melatonin Treatment Study

Unknown Blindness trial by Oregon Health and Science University. Stop reason: OTHER/UNKNOWN.

Unique provision in the American Recovery and Reinvestment Act prevented approval of second year no-cost-extension in which completion of analyses were planned.

NCT00692094: Blind Elderly Melatonin Treatment Study

Unknown Blindness trial by Oregon Health and Science University. Stop reason: OTHER/UNKNOWN.

Unique provision in the American Recovery and Reinvestment Act prevented approval of second year no-cost-extension in which completion of analyses were planned.

NCT03805672: Below Knee DVT Study

Phase IV Deep Vein Thrombosis (DVT) trial by Oregon Health and Science University. Stop reason: OPERATIONAL.

Terminated due to low enrollment because of decrease in DVT rates.